HLA class I allelic sequence and conformation regulate leukocyte Ig-like receptor binding - PubMed

Affiliations

• PMID: 21270408
• DOI: 10.4049/jimmunol.1003078

Comparative Study

HLA class I allelic sequence and conformation regulate leukocyte Ig-like receptor binding

Des C Jones et al. J Immunol. 2011.

Abstract

Leukocyte Ig-like receptors (LILRs) are a family of innate immune receptors predominantly expressed by myeloid cells that can alter the Ag presentation properties of macrophages and dendritic cells. Several LILRs bind HLA class I. Altered LILR recognition due to HLA allelic variation could be a contributing factor in disease. We comprehensively assessed LILR binding to >90 HLA class I alleles. The inhibitory receptors LILRB1 and LILRB2 varied in their level of binding to different HLA alleles, correlating in some cases with specific amino acid motifs. LILRB2 displayed the weakest binding to HLA-B*2705, an allele genetically associated with several autoimmune conditions and delayed progression of HIV infection. We also assessed the effect of HLA class I conformation on LILR binding. LILRB1 exclusively bound folded β(2)-microglobulin-associated class I, whereas LILRB2 bound both folded and free H chain forms. In contrast, the activating receptor LILRA1 and the soluble LILRA3 protein displayed a preference for binding to HLA-C free H chain. To our knowledge, this is the first study to identify the ligand of LILRA3. These findings support the hypothesis that LILR-mediated detection of unfolded versus folded MHC modulates immune responses during infection or inflammation.

Similar articles

• Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d).

  Shiroishi M, Kuroki K, Rasubala L, Tsumoto K, Kumagai I, Kurimoto E, Kato K, Kohda D, Maenaka K. Shiroishi M, et al. Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16412-7. doi: 10.1073/pnas.0605228103. Epub 2006 Oct 20. Proc Natl Acad Sci U S A. 2006. PMID: 17056715 Free PMC article.

• HLA-B27 homodimers and free H chains are stronger ligands for leukocyte Ig-like receptor B2 than classical HLA class I.

  Giles J, Shaw J, Piper C, Wong-Baeza I, McHugh K, Ridley A, Li D, Lenart I, Antoniou AN, DiGleria K, Kuroki K, Maenaka K, Bowness P, Kollnberger S. Giles J, et al. J Immunol. 2012 Jun 15;188(12):6184-93. doi: 10.4049/jimmunol.1102711. Epub 2012 May 16. J Immunol. 2012. PMID: 22593621 Free PMC article.

• LILRA3 binds both classical and non-classical HLA class I molecules but with reduced affinities compared to LILRB1/LILRB2: structural evidence.

  Ryu M, Chen Y, Qi J, Liu J, Fan Z, Nam G, Shi Y, Cheng H, Gao GF. Ryu M, et al. PLoS One. 2011 Apr 29;6(4):e19245. doi: 10.1371/journal.pone.0019245. PLoS One. 2011. PMID: 21559424 Free PMC article.

• Functional and genetic diversity of leukocyte immunoglobulin-like receptor and implication for disease associations.

  Hirayasu K, Arase H. Hirayasu K, et al. J Hum Genet. 2015 Nov;60(11):703-8. doi: 10.1038/jhg.2015.64. Epub 2015 Jun 4. J Hum Genet. 2015. PMID: 26040207 Review.

• Recognition of classical and heavy chain forms of HLA-B27 by leukocyte receptors.

  Allen RL, Trowsdale J. Allen RL, et al. Curr Mol Med. 2004 Feb;4(1):59-65. doi: 10.2174/1566524043479329. Curr Mol Med. 2004. PMID: 15011960 Review.

Cited by

• Relative expression levels of the HLA class-I proteins in normal and HIV-infected cells.

  Apps R, Meng Z, Del Prete GQ, Lifson JD, Zhou M, Carrington M. Apps R, et al. J Immunol. 2015 Apr 15;194(8):3594-600. doi: 10.4049/jimmunol.1403234. Epub 2015 Mar 9. J Immunol. 2015. PMID: 25754738 Free PMC article.

• Glatiramer Acetate Enhances Myeloid-Derived Suppressor Cell Function via Recognition of Paired Ig-like Receptor B.

  van der Touw W, Kang K, Luan Y, Ma G, Mai S, Qin L, Bian G, Zhang R, Mungamuri SK, Hu HM, Zhang CC, Aaronson SA, Feldmann M, Yang WC, Chen SH, Pan PY. van der Touw W, et al. J Immunol. 2018 Sep 15;201(6):1727-1734. doi: 10.4049/jimmunol.1701450. Epub 2018 Aug 1. J Immunol. 2018. PMID: 30068593 Free PMC article.

• LILRB4, an immune checkpoint on myeloid cells.

  Yang T, Qian Y, Liang X, Wu J, Zou M, Deng M. Yang T, et al. Blood Sci. 2022 May 17;4(2):49-56. doi: 10.1097/BS9.0000000000000109. eCollection 2022 Apr. Blood Sci. 2022. PMID: 35957669 Free PMC article. Review.

• Leukocyte immunoglobulin-like receptors in human diseases: an overview of their distribution, function, and potential application for immunotherapies.

  Zhang J, Mai S, Chen HM, Kang K, Li XC, Chen SH, Pan PY. Zhang J, et al. J Leukoc Biol. 2017 Aug;102(2):351-360. doi: 10.1189/jlb.5MR1216-534R. Epub 2017 Mar 28. J Leukoc Biol. 2017. PMID: 28351852 Free PMC article. Review.

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

• Full Text Sources

  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database

• Research Materials

  • NCI CPTC Antibody Characterization Program